Company Registration No. 12196528 (England and Wales)
Map Pharma Ltd
Filleted accounts
for the year ended 30 September 2025
Map Pharma Ltd
Filleted accounts
Contents
Map Pharma Ltd
Company Information
for the year ended 30 September 2025
Director
Muhammed Ahmed Pandor
Company Number
12196528 (England and Wales)
Registered Office
80 Osmaston Road
Leicester
LE5 5JG
Accountants
YP Finance
Hawthorne House
17A Hawthorne Drive
Leicester
Leicestershire
LE5 6DL
Map Pharma Ltd
Statement of financial position
as at 30 September 2025
Tangible assets
33,110
49,820
Cash at bank and in hand
143,651
90,964
Creditors: amounts falling due within one year
(143,008)
(75,146)
Net current assets
161,882
142,985
Total assets less current liabilities
194,992
192,805
Creditors: amounts falling due after more than one year
(74,484)
(73,964)
Net assets
120,508
118,841
Called up share capital
1
1
Profit and loss account
120,507
118,840
Shareholders' funds
120,508
118,841
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 15 June 2026 and were signed on its behalf by
Muhammed Ahmed Pandor
Director
Company Registration No. 12196528
Map Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2025
Map Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12196528. The registered office is 80 Osmaston Road, Leicester, LE5 5JG.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
25% straight line
Fixtures & fittings
25% straight line
Computer equipment
25% straight line
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Map Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2025
4
Tangible fixed assets
Motor vehicles
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At 1 October 2024
45,408
11,864
9,571
66,843
At 30 September 2025
45,408
11,864
9,571
66,843
At 1 October 2024
946
8,898
7,179
17,023
Charge for the year
11,352
2,966
2,392
16,710
At 30 September 2025
12,298
11,864
9,571
33,733
At 30 September 2025
33,110
-
-
33,110
At 30 September 2024
44,462
2,966
2,392
49,820
Finished goods
19,500
10,567
Amounts falling due within one year
Trade debtors
108,540
79,155
Accrued income and prepayments
1,070
1,698
7
Creditors: amounts falling due within one year
2025
2024
Trade creditors
135,258
58,789
Taxes and social security
6,059
15,295
8
Creditors: amounts falling due after more than one year
2025
2024
Other creditors
74,484
73,964
Allotted, called up and fully paid:
1,000 Ordinary shares of £0.001 each
1
1
Map Pharma Ltd
Notes to the Accounts
for the year ended 30 September 2025
10
Average number of employees
During the year the average number of employees was 6 (2024: 6).